Table of contents

Cardiovascular and metabolic risk

• Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis (20 February, 2023)

  Sicheng Wang, Xiangyuan Zhang, Qiqi Zhang, Boxun Zhang, Linhua Zhao
• Invasive validation of the Antares algorithm for determining central blood pressure based on upper arm oscillometric pulse waves in patients with type 2 diabetes (27 January, 2023)

  Alexander Stäuber, Cornelia Piper, Marco Köster, Marcus Dörr, Stefan Richter, Marc-Alexander Ohlow, Siegfried Eckert, Johannes Baulmann
• Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients (20 January, 2023)

  Orna Reges, Tsafnat Test, Moshe Hoshen, Assi Cicurel, Walid Saliba, Philip Greenland, Dror Dicker, Gil Lavie
• Prevalence of, and factors associated with, diabetes mellitus in people with severe mental illness attending a multidisciplinary, outpatient cardiometabolic health assessment service (18 January, 2023)

  Tim Lambert, Tim Middleton, Roger Chen, Premala Sureshkumar
• Diabetes with poor-control HbA1c is cardiovascular disease ‘risk equivalent’ for mortality: UK Biobank and Hong Kong population-based cohort study (12 January, 2023)

  Eric Yuk Fai Wan, Esther Yee Tak Yu, Ivy Lynn Mak, Hin Moi Youn, Kam Suen Chan, Esther W Y Chan, Ian C K Wong, Cindy Lo Kuen Lam
• How sweet is your love? Disentangling the role of marital status and quality on average glycemic levels among adults 50 years and older in the English Longitudinal Study of Ageing (6 February, 2023)

  Katherine J Ford, Annie Robitaille